The transcription factor Nanog plays a crucial role in the maintenance of the undifferentiated state of embryonic stem cells [1, 2] . Like Oct-4, it has been accepted as an important mark for pluripotent cells.
Previous studies suggested that Oct-4 and Nanog work in parallel pathways. The loss of Nanog does not affect oct-4 gene expression, and the loss of oct-4 does not affect Nanog gene expression in the blastocyst [2] . However, there were evidences showing that Oct-4 is necessary for Nanog gene expression [3] , which was confirmed by recent reports that Oct-4 and Sox-2 synergistically activate Nanog gene expression [4, 5] .
The Oct-4 and Sox-2 binding sites are located within the differentially regulated Nanog promoter region and responsible for its activity [6] . However, overexpression of Oct4 and Sox-2 have little effect on rescuing Nanog promoter activity in differentiated cells [4] , indicating that some other transcription factors, besides Oct4 and Sox2, may be required for the regulation of Nanog gene expression [4] . In this work, we tried to find other cis-elements within the Nanog promoter participating in the Nanog gene transcriptional regulation.
Materials and Methods

Cell culture and transient transfection
F9 EC cells were maintained in Dulbecco's modified Eagle's medium (DMEM) (Life Technologies) supplemented with 10% fetal bovine serum (Hyclone). Cells were seeded at 5 × 10 4 cells per well in 24 well plates 24 h prior to transfection. 1 mg each of the promoter reporters constructs and 0.02 mg pRL-TK (Promega) were co-transfected in duplicate by LipofectAMINE 2000 according to the manufacturer's instructions. Cells were then lysed with 100 ml passive lysis buffer (Promega) 24 h after transfection and the cell lysates were vortexed and briefly centrifuged to sediment cell debris. 20 ml aliquot of cell lysate was then assayed for luciferase activities using the Dual Luciferase Reporter (DLR) assay system (Promega) according to the supplier's recommendations. All transfections were repeated three times and shown with representative samples. Plasmid DNA was purified using Qiagen tip-20 column. Dominant negative Sp1 and Sp3 expression constructs were gifts from Prof Thiel G. To create the mutant constructs pNANPmSP1A, pNANPmSP1B and pNANPmSP1AB, the putative Sp1 binding sequence was replaced by introducing Nhe I and Xba I sites with a method based on bridging-based two round PCR [7] with PNANP-220/+6 as template. The primers are listed in Table 1 .
Nuclear extract preparation and electrophoretic gel mobility shift assay
Nuclear proteins were extracted from F9 EC cells as previously described [8] . Complementary oligonucleotides (as shown in Table  1 ) were annealed in annealing buffer (10 mM Tris-Cl, pH 7.5, 1 mM EDTA, 100 mM NaCl) and the resulting double-stranded oligodeoxynucleotide (dsODN) probes were end-labeled with [γ-32 P] ATP by T4 polynucleotide kinase (Tarkara). For gel mobility shift assays, 2 × 10 4 cpm probe was incubated with 4 mg of nuclear extracts in 20 ml volume of binding reaction buffer (10 mM Tris-Cl, pH 7.5, 50 mM NaCl, 1 mM MgCl 2 , 0.5 mM EDTA, 5 % glycerol, 0.05 mg/mL Poly (dI/dC)) or sperm DNA on ice for 30 min. 50 or 100 fold molar excess of the individual double-stranded oligonecleotides were included in the binding reaction for both specific and non-specific competition analyses. In supershift experiments, Sp1 (PEP-2) or Sp3 (D20) polyclone antibody (Santa Cruz) was incubated with nuclear extracts in a 20 ml volume of binding reaction for 30 min on ice, followed by incubation with the labeled probe on ice for an additional 30 min. Complexes were separated on 4% non-denaturing polyacrylamide gels. The gels were subsequently dried and autoradiography was performed.
Results and Discussion
Like many other genes in early embryo as fgf4, sox-2, utf1 and fbx15, Nanog gene expression is regulated by Oct-4 and Sox-2 synergistically [4, 5] . However, overexpression of Oct-4 or Sox-2, or both, could not effectively activate the Nanog gene promoter [5] . Here we further analyzed other putative bindings sites located within the same promoter region, which may be responsible for Nanog promoter activity. Two putative Sp1 binding sites centered at -50 and -76 were revealed using TRANSFAC and GENOMATIX softwares. To characterize the functions of those sites, mutation analyses were carried out. The putative Sp1 binding sites centered at -50 and -76 were mutated by replacing the original nucleotides with sequences of restriction enzyme sites that lack any known cis-element. As Figure 1 showed, compared to the wild-type construct, mutation of the site at -76 reduced Nanog promoter activity approximately by 50%, and mutation of the site at -50 decreased the reporter activity by nearly 5 times, suggesting that the two putative Sp1 binding sites might be critical for Nanog expression. Moreover, double mutation of the two sites decreased Nanog promoter activity by nearly 20 times, indicating that the two sites may act synergistically. Although a third putative Sp1 binding site was revealed at -110 by software analyses, mutation of the site did not affect Nanog promoter activity (data not shown).
EMSA was then carried out to search for the proteins binding to the putative Sp1 sites. Oligonucleotides containing the two putative Sp1 sites were synthesized and labeled with [γ -32 P]-ATP as probes and incubated with F9 cell nuclear extracts. Data showed that three shift bands were formed with either probe (Figure 2A and 2B) .The intensity of the three bands were significantly reduced by the addition of 50 × molar excess cold Sp1 oligonucleotide, but not by addition of non specific competitor (Figure 2A and 2B) , which confirmed the specificity of the proteins binding to the two putative Sp1 sites. Supershift experiments showed that addition of Sp1 antibody inhibited the formation of the upper band, and the two bands below were inhibited by addition of Sp3 antibody, indicating that the two sites selectively bound Sp1 and Sp3 (Figure 2A and 2C) . The sequence at site -50 showed stronger binding affinities to Sp1/Sp3 than the one at -76, which is in agreement with the results of above mutation promoter assay, proposing the downstream site might contribute more to the promoter activity than the upstream one.
To further confirm the role of Sp1 and Sp3 on the regulation of the Nanog promoter activation, co-transfection experiments with dominant-negative (DN) mutants of Sp1 and Sp3 were carried out. DN mutants of Sp1 and Sp3 contain intact DNA binding regions, but lack any transcriptional activation function. They could effectively block Sp1 or Sp3 DNA binding sites [9] . In this experiment, F9 EC cells were co-transfected with the wild type reporter plasmids and expression vectors of dominant negative mutants of Sp1 or Sp3, namely GST-Sp1 or GST-Sp3. As a control, an expression vector encoding a nuclear-targeted glutathione S-transferase (GST) was used. The results showed that expression of either GST-Sp1 or GST-Sp3 resulted in an Cell Research | www.cell-research.com
Functional analysis of Sp1/Sp3 binding sites in murine Nanog promoter 322 npg obvious decrease in the Nanog promoter activity ( Figure  3 ). The inhibitory effects were much more significant in human TERA-2 EC cells, the reason of which may be that the human gene promoter was used to create GST-Sp1 and GST-Sp3. These data indicate that both Sp1 and Sp3 bind the two putative Sp1 sites within the Nanog promoter and they may participate in the regulation of the constitutive transcriptional activity of Nanog gene.
Sp1 and Sp3 are two ubiquitously expressed transcription factors and belong to the Sp1-like/KLF family of the transcription factors. Members of this family are implicated in the regulation of diverse cellular functions [10, 11] . Sp1 and Sp3 participate in the activation of oct-4 expression, which is differentially regulated during mouse development [12] . Here we report that they are also involved in murine Nanog gene transcriptional regulation. However, Sp1 or Sp3 knockout mice were still able to form intact inner cell mass [13, 14] , suggesting that Sp1 and Sp3 have redundant functions that compensate for each other in Sp1 or Sp3 knockout mice, Perhaps the generation of ES cells with double knockout of Sp1 and Sp3 will unravel the question. 
